A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers’ reimbursement rises to cover its high cost, according to researchers from the University…
Continue Reading
News Source: medicalxpress.com
Leave a Reply